IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19

IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Laboratory medicine 2024-05, Vol.55 (3), p.373-379
Hauptverfasser: Melayah, Sarra, Omrani, Nouha, Alouini, Hela, Ghozzi, Mariam, Mrad, Sawssen, Boussarsar, Mohamed, Chaouch, Houda, Hachfi, Wissem, Letaief, Amel, Mankaï, Amani, Ghedira, Ibtissem
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 379
container_issue 3
container_start_page 373
container_title Laboratory medicine
container_volume 55
creator Melayah, Sarra
Omrani, Nouha
Alouini, Hela
Ghozzi, Mariam
Mrad, Sawssen
Boussarsar, Mohamed
Chaouch, Houda
Hachfi, Wissem
Letaief, Amel
Mankaï, Amani
Ghedira, Ibtissem
description
doi_str_mv 10.1093/labmed/lmad097
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_labmed_lmad097</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_labmed_lmad097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c847-54f9d476de527b3fcd75c85a8bad5b0013202e7278a4781d14586c50312c4b8b3</originalsourceid><addsrcrecordid>eNotkEtqwzAYhEVpoW7abde6gJNfL0teBvdlCGSTdmtkSU5U_MISFF-rB-mZ6pBsZphZDMOH0DOBNYGcbVpdd85u2k5byOUNSkjOWSolg1uUAIBMBVB5jx5C-F4izzOaoM_yuMU-4HhyeJycHTrf6z4u1RDn0eGhwUv0Kf77xRQf29kM4zRE53tc4kVGHb3rY8A_Pp5wsf8qX1KSP6K7RrfBPV19hQ5vr4fiI93t38tiu0uN4ssd3uSWy8w6QWXNGmOlMEpoVWsragDCKFAnqVSaS0Us4UJlRgAj1PBa1WyF1pdZMw0hTK6pxsl3eporAtWZSXVhUl2ZsH9LWlZU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19</title><source>Oxford University Press</source><creator>Melayah, Sarra ; Omrani, Nouha ; Alouini, Hela ; Ghozzi, Mariam ; Mrad, Sawssen ; Boussarsar, Mohamed ; Chaouch, Houda ; Hachfi, Wissem ; Letaief, Amel ; Mankaï, Amani ; Ghedira, Ibtissem</creator><creatorcontrib>Melayah, Sarra ; Omrani, Nouha ; Alouini, Hela ; Ghozzi, Mariam ; Mrad, Sawssen ; Boussarsar, Mohamed ; Chaouch, Houda ; Hachfi, Wissem ; Letaief, Amel ; Mankaï, Amani ; Ghedira, Ibtissem</creatorcontrib><identifier>ISSN: 0007-5027</identifier><identifier>EISSN: 1943-7730</identifier><identifier>DOI: 10.1093/labmed/lmad097</identifier><language>eng</language><ispartof>Laboratory medicine, 2024-05, Vol.55 (3), p.373-379</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c847-54f9d476de527b3fcd75c85a8bad5b0013202e7278a4781d14586c50312c4b8b3</citedby><cites>FETCH-LOGICAL-c847-54f9d476de527b3fcd75c85a8bad5b0013202e7278a4781d14586c50312c4b8b3</cites><orcidid>0000-0001-6525-689X ; 0000-0002-5424-0750 ; 0000-0003-4455-6513</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Melayah, Sarra</creatorcontrib><creatorcontrib>Omrani, Nouha</creatorcontrib><creatorcontrib>Alouini, Hela</creatorcontrib><creatorcontrib>Ghozzi, Mariam</creatorcontrib><creatorcontrib>Mrad, Sawssen</creatorcontrib><creatorcontrib>Boussarsar, Mohamed</creatorcontrib><creatorcontrib>Chaouch, Houda</creatorcontrib><creatorcontrib>Hachfi, Wissem</creatorcontrib><creatorcontrib>Letaief, Amel</creatorcontrib><creatorcontrib>Mankaï, Amani</creatorcontrib><creatorcontrib>Ghedira, Ibtissem</creatorcontrib><title>IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19</title><title>Laboratory medicine</title><issn>0007-5027</issn><issn>1943-7730</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNotkEtqwzAYhEVpoW7abde6gJNfL0teBvdlCGSTdmtkSU5U_MISFF-rB-mZ6pBsZphZDMOH0DOBNYGcbVpdd85u2k5byOUNSkjOWSolg1uUAIBMBVB5jx5C-F4izzOaoM_yuMU-4HhyeJycHTrf6z4u1RDn0eGhwUv0Kf77xRQf29kM4zRE53tc4kVGHb3rY8A_Pp5wsf8qX1KSP6K7RrfBPV19hQ5vr4fiI93t38tiu0uN4ssd3uSWy8w6QWXNGmOlMEpoVWsragDCKFAnqVSaS0Us4UJlRgAj1PBa1WyF1pdZMw0hTK6pxsl3eporAtWZSXVhUl2ZsH9LWlZU</recordid><startdate>20240502</startdate><enddate>20240502</enddate><creator>Melayah, Sarra</creator><creator>Omrani, Nouha</creator><creator>Alouini, Hela</creator><creator>Ghozzi, Mariam</creator><creator>Mrad, Sawssen</creator><creator>Boussarsar, Mohamed</creator><creator>Chaouch, Houda</creator><creator>Hachfi, Wissem</creator><creator>Letaief, Amel</creator><creator>Mankaï, Amani</creator><creator>Ghedira, Ibtissem</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-6525-689X</orcidid><orcidid>https://orcid.org/0000-0002-5424-0750</orcidid><orcidid>https://orcid.org/0000-0003-4455-6513</orcidid></search><sort><creationdate>20240502</creationdate><title>IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19</title><author>Melayah, Sarra ; Omrani, Nouha ; Alouini, Hela ; Ghozzi, Mariam ; Mrad, Sawssen ; Boussarsar, Mohamed ; Chaouch, Houda ; Hachfi, Wissem ; Letaief, Amel ; Mankaï, Amani ; Ghedira, Ibtissem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c847-54f9d476de527b3fcd75c85a8bad5b0013202e7278a4781d14586c50312c4b8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melayah, Sarra</creatorcontrib><creatorcontrib>Omrani, Nouha</creatorcontrib><creatorcontrib>Alouini, Hela</creatorcontrib><creatorcontrib>Ghozzi, Mariam</creatorcontrib><creatorcontrib>Mrad, Sawssen</creatorcontrib><creatorcontrib>Boussarsar, Mohamed</creatorcontrib><creatorcontrib>Chaouch, Houda</creatorcontrib><creatorcontrib>Hachfi, Wissem</creatorcontrib><creatorcontrib>Letaief, Amel</creatorcontrib><creatorcontrib>Mankaï, Amani</creatorcontrib><creatorcontrib>Ghedira, Ibtissem</creatorcontrib><collection>CrossRef</collection><jtitle>Laboratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melayah, Sarra</au><au>Omrani, Nouha</au><au>Alouini, Hela</au><au>Ghozzi, Mariam</au><au>Mrad, Sawssen</au><au>Boussarsar, Mohamed</au><au>Chaouch, Houda</au><au>Hachfi, Wissem</au><au>Letaief, Amel</au><au>Mankaï, Amani</au><au>Ghedira, Ibtissem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19</atitle><jtitle>Laboratory medicine</jtitle><date>2024-05-02</date><risdate>2024</risdate><volume>55</volume><issue>3</issue><spage>373</spage><epage>379</epage><pages>373-379</pages><issn>0007-5027</issn><eissn>1943-7730</eissn><doi>10.1093/labmed/lmad097</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-6525-689X</orcidid><orcidid>https://orcid.org/0000-0002-5424-0750</orcidid><orcidid>https://orcid.org/0000-0003-4455-6513</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-5027
ispartof Laboratory medicine, 2024-05, Vol.55 (3), p.373-379
issn 0007-5027
1943-7730
language eng
recordid cdi_crossref_primary_10_1093_labmed_lmad097
source Oxford University Press
title IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A21%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IgA%20is%20the%20predominant%20isotype%20of%20anti-%20%CE%B2%202%20glycoprotein%20I%20in%20patients%20with%20COVID-19&rft.jtitle=Laboratory%20medicine&rft.au=Melayah,%20Sarra&rft.date=2024-05-02&rft.volume=55&rft.issue=3&rft.spage=373&rft.epage=379&rft.pages=373-379&rft.issn=0007-5027&rft.eissn=1943-7730&rft_id=info:doi/10.1093/labmed/lmad097&rft_dat=%3Ccrossref%3E10_1093_labmed_lmad097%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true